Poolbeg Pharma PLC (LON:POLB – Get Free Report)’s share price shot up 12.8% during mid-day trading on Friday . The stock traded as high as GBX 5.30 ($0.07) and last traded at GBX 5.30 ($0.07). 1,229,697 shares were traded during trading, a decline of 81% from the average session volume of 6,431,729 shares. The stock had previously closed at GBX 4.70 ($0.06).
Analysts Set New Price Targets
Separately, Shore Capital reissued a “house stock” rating on shares of Poolbeg Pharma in a research report on Thursday, January 2nd.
Get Our Latest Report on Poolbeg Pharma
Poolbeg Pharma Stock Performance
Poolbeg Pharma Company Profile
Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.
Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.
Recommended Stories
- Five stocks we like better than Poolbeg Pharma
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Bloom Energy: Powering the Future With Decentralized Energy
- How to Calculate Inflation Rate
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Roth IRA Calculator: Calculate Your Potential Returns
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
